Diabetes mellitus groups heterogeneous etiologies, but shares abnormalities in carbohydrate, fat and protein metabolisms. Long-term diabetes affects many organ systems. The vascular consequences of the disease can be subdivided into microvascular (retinopathy and nephropathy) and macrovascular complications (coronary and peripheral arterial disease).
Whereas the former lesions are relatively unique for diabetes, the latter are similar both morphologically and functionally with atherosclerotic lesions due to other causes. Since diabetes is such an important risk factor for the occurrence of atherosclerosis and coronary heart disease, not surprisingly cardiovascular disease is the leading cause of morbidity and mortality in diabetic patients 1 .
A large body of evidence demonstrates the impairment of endothelium-dependent vasodilatation in cardiovascular diseases such as hypertension, hypercholesterolemia, atherosclerosis, and heart failure [2] [3] [4] [5] . However the available data are not so conclusive as regards to diabetes 6 . Thus, the present non-exhaustive review will focus on the impact of diabetes on vascular dysfunction, in particular on endothelium-derived vasoactive factors.
Endothelial Dysfunction in Diabetes
Endothelium-derived Nitric oxide is essential for the local control of vascular diameter [7] [8] [9] .
In type I diabetic animals, acetylcholine-induced relaxations are potentiated in the rat aorta and canine coronary arteries [10] [11] [12] , normal in the aorta [13] [14] [15] [16] and the mesenteric arteries 14 of the rat, and/or depending on the authors, blunted in the same blood vessels [17] [18] . Moreover, NOmediated relaxation is augmented at the early stage of diabetes followed by an impaired relaxation as the disease progresses [19] [20] . Likewise, in type I diabetes patients, endotheliumdependent relaxations are impaired 4, [21] [22] [23] , normal [24] [25] [26] [27] [28] or enhanced 29 .
In type II diabetic animals, NO-mediated relaxation is increased 30 , preserved 31 or reduced 32 in the aorta of obese Zucker fatty rats. Blunted NO-mediated relaxations are observed in carotid and mesenteric arteries from Zucker rats [33] [34] , mesenteric arteries from db/db mice [35] [36] and coronary arteries of db/db mice [37] [38] . In type II diabetes patients, blunted dilatations are observed consistently [39] [40] . The evidence suggesting an impairment of endothelium-dependent vasodilatation in type II diabetes is more obvious than in type I diabetes, since the former is almost inevitably confounded by the high prevalence of other cardiovascular risk factors that are known to affect endothelial functions 41 . Several studies demonstrated impaired endothelium-dependent vasodilatation in patients with type II diabetes, but even after rigorous patient selection, mild dyslipidaemia or hypertension were often present [42] [43] . Thus it remains unclear whether or not diabetes type II per se affects endothelial function.
Prostacyclin (PGI 2 )
is not only an endothelium-derived relaxing factor 44-46 but also is an important inhibitor of platelet aggregation 47 .
In type I diabetes, prostacyclin contributes to the enhanced acetylcholine-induced and endothelium-dependent relaxation in the coronary artery of dogs 10 and the aorta of the mouse 48 . In addition, the oral administration of prostacyclin analogues restores the blunted 5 relaxation to acetylcholine in the rat aorta 49 . These results indicate that prostacyclin takes part in the preservation of endothelium-dependent relaxation in diabetes, especial in type I.
Endothelium-derived hyperpolarizing factors (EDHF) represent the third endotheliumdependent vasodilator pathway(s)
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EDHF-mediated responses are observed in certain blood vessels in the presence of inhibitors of cyclooxygenases and NO synthases and are associated with hyperpolarization of the vascular smooth muscle cell [50] [51] [52] [53] [54] [55] . EDHFs play a more pronounced role in the smaller arteries [56] [57] . They are also regarded as an important compensatory mechanism in the absence or blockade of the production of nitric oxide [58] [59] [60] [61] [62] . However the correlation between diabetes and endothelium-dependent hyperpolarization remains unclear.
In type I diabetes, the endothelium-dependent response to acetylcholine attributed to EDHF is depressed in isolated rings of mesenteric arteries from streptozotocin-treated rats and mice, while the nitric oxide component is preserved [63] [64] [65] [66] . .
Endothelium-derived and cyclooxygenase-dependent contracting factor (EDCF) is a hallmark of endothelial dysfunction. The product of cyclooxygenase activates thromboxaneprostanoid (TP-) receptors [71] [72] [73] [74] [75] . The nature of endothelium-derived contracting factor depends 6 on the experimental model studied and the stimulating agents used. It can be endoperoxide [76] [77] , thromboxane A 2 [78] [79] , prostaglandin E 2
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, or prostacyclin [80] [81] [82] .
In type I diabetes, the EDCF-mediated response is potentiated in the aorta of rabbits 83 , the aorta of mice 84 and the femoral artery of rats (Figure 1 ) 79 . In the mesenteric artery from rats with alloxan-induced diabetes, an increased production of prostanoids, presumable prostaglandin F 2α , reduces the arterial diameter 85 .
In the renal artery of a type II diabetes model, the OLETF rat, indomethacin restores the blunted relaxation to acetylcholine 86 . Similar results were obtained in the aorta from db/db mice 87 . An augmented EDCF-mediated contraction is observed in the mesenteric artery of OLETF rats [88] [89] .
Endothelin (ET)
is also a hallmark of endothelial dysfunction. The contribution of ET-1 is not obvious in the early stages of diseases, indicating that the production of endothelin reflects an advanced or even terminal pathology 90 .
An ET-1 antagonist, J-104132 normalizes the up-regulation of p22phox subunit of NAD(P)H oxidase in streptozotocin-treated rats 91 . Moreover, the dual blockade of ETA and ETB receptors enhances the endothelium-dependent vasodilatation to acetylcholine in insulinresistant patients 92 . These observations suggest that ET-1 may play a role in the endothelial dysfunction of diabetes.
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Reactive Oxygen Specials in Diabetes
Reactive oxygen specials (ROS) are generated during normal metabolic processes, but at supra physiological levels they cause DNA mutation, protein oxidation and lipid peroxidation. Unlike superoxide anion, hydrogen peroxide diffuses freely within tissues since it is not charged. The metal catalyzed interaction between hydrogen peroxide and superoxide anion produces hydroxyl radical. Reactive oxygen species can either be generated exogenously or produced intracellularly from several different sources. Cytosolic enzyme systems contributing to oxidative stress include the family of NADPH oxidases 94 , mitochondria 95 . In addition, xanthine oxidase, cytochrome P450(s), cyclooxygenases and NO synthase are capable of producing reactive oxygen species 96 .
The burden of free radical production is largely counteracted by the antioxidant defense system that includes the enzymatic scavenger superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx). Superoxide dismutase speeds up the conversion of superoxide anions to hydrogen peroxide, whereas catalase and glutathione peroxidase convert hydrogen peroxide to water. A variety of other non-enzymatic, low molecular mass molecules are important in scavenging reactive oxygen species. These include ascorbate, pyruvate, flavonoids, and carotenoids, and perhaps most importantly, glutathione, which is present in millimolar concentrations within cells ( Figure 2 ).
Imbalance of the oxygen-derived free radicals and antioxidant defense
Diabetes increases the level of reactive oxygen species [96] [97] [98] [99] [100] [101] [102] . These radicals play a crucial role in the pathogenesis of diabetes-associated vascular complications 96, [103] [104] [105] . However, neither the exact source of the free radicals initiating the cascade leading to cell dysfunction in diabetes nor their exact chemical nature is fully understood. Under hyperglycemic and diabetic conditions, glycation reactions produce intermediate compounds that also increase the levels of reactive oxygen species 6, 103, [106] [107] [108] [109] [110] [111] . Dicarbonyl compounds such as methyglyoxal and 3-deoxyglucosone, intermediate products of glycation, are typical examples.
The serum concentrations of both methyglyoxal and 3-deoxyglucosone are increased in patients with diabetes mellitus 112 .
In diabetes, it is also reported that the augmented production of oxidative specials results from a reduced activity of superoxide dismutase ( Figure 3 
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, from reduced total glutathione level 100, 118 , from increased activity of glutathione peroxidase [119] [120] , and from up-regulation of NADPH oxidase 34, 38, 115, 121-122 and cyclooxygenase ( Figure 5 ) 79, [88] [89] 123 .
NO and ROS
Obviously nitric oxide is not the sole answer to the endothelial dysfunction of diabetes. The obligatory role of endothelium-derived nitric oxide was first reported in 1980 7 . It is generated through the oxidation of L-arginine to L-citrulline by NO synthase (NOS). In blood vessels, endothelial NO synthase (eNOS) is constitutively active in the endothelium but the activity of the enzyme can be augmented further by stimuli that increase the intracellular calcium concentration 124 . The impact of diabetes on the presence of nitric oxide synthase is controversial. It is reduced 34, 37, 88, 116, 125 , normal 79, 123, [126] [127] , or enhanced [128] [129] . Since nitric oxide has a half-life of only a few seconds 130 and is rapidly inactivated by hemoglobin and superoxide 8, 130 , the concept of loss of nitric oxide bioavailability is more precise and Uncoupled eNOS is an important source of reactive oxygen species under pathological condition [134] [135] . The production of peroxynitrite, a strong cytotoxic oxidant which is formed by the combination of nitric oxide and superoxide anions, also contributes to endothelial dysfunction 129, 136 . When prostacyclin synthase in isolated arteries is inactivated by peroxynitrition, prostacyclin-dependent vasodilatation is replaced by prostaglandin-dependent vasoconstriction 131 .
EDHF and ROS
Since the correlation between diabetes and endothelium-dependent hyperpolarization is inconclusive yet, it is difficult to link EDHF and oxidative stress. Interestingly, hydrogen peroxide is proposed to be an endothelium-derived hyperpolarizing factor in the mesenteric artery of type II diabetic mice [137] [138] , the mesenteric artery of humans 139 and the porcine coronary artery 140 .
EDCF and ROS
Oxygen-derived free radicals play an important role in the occurrence of endotheliumdependent contractions in the basilar artery of the dog and the aorta of the spontaneously hypertensive rat 74, 81, [141] [142] [143] [144] . ROS potentiates endothelium-derived contracting factor in the aorta of the spontaneously hypertensive rats 144 and the femoral artery of streptozotocininduced type I diabetic rats (unpublished observation). The potentiating effect was not observed in the artery from control rats, suggesting that the redox abnormality is seen only under certain disease conditions.
Oxygen-derive free radicals are also directly involved in the occurrence of the endothelium-derived contractions, since an increased oxidative state, measured by DCF fluorescence intensity using confocal microscopy, accompanies the genesis of endothelium-dependent contractions to acetylcholine or the calcium ionophore A23187 81, 100 . Furthermore, tiron (an intracellular scavenger of superoxide anion) reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat 144 and the femoral artery of rats with streptozotocin-induced diabetes (Figure 6a ) 100 , indicating that superoxide anions inside endothelial cells are a primary oxidative contributor to endothelium-dependent contractions 72, 100, 144 . Catalase and deferoxamine reduce the endothelium-dependent contraction in the aorta of hypertensive rats 144 and in the femoral artery of diabetic rats (Figure 6b ) 100 , suggesting that hydrogen peroxide could be, at least the precursor of endothelium-derived contracting factor.
In addition, hydroxyl radicals per se have been proposed as candidates for endotheliumderived contacting factors. In the femoral artery of streptozotocin-induced type I diabetes, hydrogen peroxide produces moderate contractions in rings without endothelium which are prevented by catalase and deferoxamine, indicating that the contraction generated by exogenous H 2 O 2 is presumably due to hydroxyl radicals, rather than hydrogen peroxide itself.
The hydroxyl radicals-mediated contraction is comparable in amplitude to the deferoxaminesensitive part of the endothelium-dependent contraction in the same artery 100 . A similar conclusion has been reached in the aorta of spontaneously hypertensive rats 144 .
Antioxidant treatment
It seems reasonable to hypothesize that antioxidant treatment would prevent endothelial dysfunction in diabetes. In diabetic animals, vitamin E alone or combined with insulin prevents endothelial dysfunction 97, 145 . Exercise which is assumed to reduce oxidative stress in vivo improves endothelial dysfunction 116 . Folic acid restores the impaired endothelial function as well 41 . Likewise, in diabetes patients, vitamin E, vitamin C, or folic acid improve endothelial dysfunction [147] [148] [149] [150] [151] . However, trials with these beneficial results are carried out in small-groups of patients whereas in large, long-term clinical trials, neither vitamin E nor vitamin C reduces the risk of cardiovascular events [152] [153] [154] . Therefore, caution is required before drawing a conclusion as to the effectiveness of antioxidant treatments in vivo for the prevention of endothelial dysfunction in diabetes.
Conclusion
The endothelial dysfunction of diabetes includes reduced nitric oxide bioavailability and/or enhanced endothelium-dependent contractions which can be largely attributed to increased oxidative stress (Figure 7 ). Since the results of antioxidants in large clinic trials are not consistent with those in experimental animals, further investigation is critical to assess the exact role of ROS on the genesis of endothelial dysfunction, in particular in diabetes. 
